AI and Plant Medicine: Two Exits from the Same Room
By Dr. David Wiss
The simultaneous rise of AI and plant medicine looks like a cultural contradiction. In my clinical practice, it isn’t. Both are responses to the same underlying mental health crisis, a body and a nervous system signaling that this version of being human is no longer working. Same hunger, different doors. This piece looks at why the newest machines and the oldest medicines are being reached for at the same time, by the same people, and what neither movement can solve on its own.
Subscribe for weekly insights and research exploring the link between nutrition & mental health.
Why two opposing cultural forces are responding to the same mental health crisis…
A patient sat across from me last month and asked me two questions in the first few minutes, about AI and plant medicine.
Should she try a continuous glucose monitor and one of those AI-driven sleep coaches? And what did I think about a psilocybin retreat she’d been considering in Oregon?
She didn’t see the questions as connected. I did. And I see some version of this patient several times a week now.
A composite of her, since she isn’t just one person: late thirties, high-functioning, exhausted. Her sleep is fragmented. Her gut has been reactive for two years, and her gastroenterologist told her she was fine. She doomscrolls until midnight, wakes at 6, opens the same apps, and arrives at her desk already depleted.
The tools she’s reaching for couldn’t look more different. The underlying request is the same.
The year ChatGPT crossed 100 million users, ayahuasca retreats in the Sacred Valley sold out months in advance. As a mental health scientist and clinician working at the intersection of functional medicine, nutrition, addiction, and trauma, I don’t think this is a coincidence.
We’re living through the simultaneous rise of two cultural movements that, on the surface, look like opposites. One is racing forward: artificial intelligence, large language models, the algorithmic expansion of human cognition into machine output. The other is reaching toward something older: ceremonial plant medicine, ancestral healing traditions, slow practices, reverence for the earth.
The shorthand practically writes itself. Future versus past. Fast versus slow. Disembodied versus embodied. Isolated versus communal.
The shorthand is wrong.
These movements aren’t opposites. They’re parallel responses to the same underlying crisis.
Same hunger, different doors.
The Strange Simultaneity
Psychedelic-assisted therapy is moving toward the mainstream. Mushroom decriminalization is spreading across jurisdictions. The language of set and setting, integration, and the medicine now appears on Instagram alongside skincare routines. Ayahuasca ceremonies are no longer confined to the Amazon; they’ve entered major US cities. Microdosing is something patients ask about the way they used to ask about CBD.
It’s worth being precise: the medicine itself isn’t “returning.” It never left. The Mazatec, Shipibo, Wixárika, Bwiti, and many other communities have carried these practices through centuries of suppression and criminalization. What’s returning is Western attention.
At the same time, artificial intelligence is reshaping work, education, and even intimacy. People are forming attachments to chatbots. Clinicians are using AI to draft notes. Students are outsourcing parts of cognition. The economic and psychological implications are substantial and still unfolding.
These stories are usually told separately. One is a technology narrative, the other is a wellness or medical narrative. In practice, they overlap. The same people often participate in both. The tech founder experimenting with microdosing is often the same person funding AI infrastructure. The patient exploring AI optimization tools is the same one asking about psychedelic retreats.
This is not a coincidence. It’s convergence.
What the Body Knows
By the time this patient is sitting across from me, the pattern is often visible at multiple levels: a stress response that struggles to downshift, disruptions in gut function, and low-grade inflammation contributing to cognitive symptoms. These are the physiological substrates functional medicine tends to focus on, and they are rarely where patients have been directed to look.
Beneath the cultural narratives of these two movements are two modes of consciousness. Two different ways of being awake in a body.
One is the mode increasingly shaped by digital environments: attention fragmented across screens, cognition externalized into tools, and a constant internal narration evaluating performance. This state is associated with increased activity in the default mode network, the circuitry involved in self-referential thought and rumination. For shorthand, call this tech-mediated consciousness. For many people (myself included), it has become the default.
The other mode is often described in the context of psychedelic experiences: reduced self-referential processing, altered perception of time, and a shift toward embodied awareness. These states tend to quiet the default mode network and open a window of neural flexibility.
Scientific language captures part of this. Traditional frameworks describe something broader: not just a shift in brain activity, but a relationship between person, body, community, and environment. Whether one adopts that ontology or not, it points to a limitation in current models.
Both movements are reaching toward a different way of inhabiting consciousness in a body that has long been signaling that this is not sustainable.
The Shared Root: A Meaning Crisis
What both movements are responding to is often described as a meaning crisis: a breakdown in shared systems that once provided identity, purpose, and belonging.
Institutional trust has declined. Religious participation is at historic lows. Economic stability feels increasingly uncertain. Loneliness is now widely recognized as a public health concern. The cultural structures that once grounded people (community, ritual, intergenerational continuity) have eroded over time.
Most of my patients don’t experience this as an abstract concept. They feel it as a lived sense of disorientation.
Artificial intelligence represents one response: build upward. Increase capacity, efficiency, and optimization. Offload cognitive burden. Extend human capability through machines.
Plant medicine represents another: move inward. Reconnect with the body, the environment, and the lineage. Reorient toward belonging rather than output.
Same question. Different directions.
The Silicon Valley Paradox
The idea that technology is the problem and plant medicine is the solution breaks down under scrutiny.
The populations driving both movements overlap. The same economic forces shaping AI are also funding psychedelic research and commercialization. And both are increasingly being absorbed into the same optimization framework they were, in some sense, meant to disrupt.
Psychedelic productivity is now a category. Digital tools are being marketed as adjuncts to altered states. The underlying mindset remains intact: optimize, improve, enhance.
Plus, let’s be honest: there’s a sourcing problem neither side wants to look at directly. AI systems have scaled by drawing from vast amounts of human-generated data, often without explicit consent. The expansion of plant medicine has, in many cases, involved extracting knowledge and resources from Indigenous traditions without adequate reciprocity.
Indigenous practitioners have articulated what reciprocity can look like: financial return to source communities, apprenticeship models, transparency about lineage, and community-level consent. Much of the current market has yet to fully engage with these expectations.
This raises a broader question: can a movement intended to heal operate within the same extractive logic that contributed to the problem?
The Questions That Actually Matter
In clinical practice, the questions that tend to matter most are often the least emphasized in both movements.
What did you eat the day after? How did you sleep that week? Who are you connected to? What plants do you engage with? What does your daily life actually look like?
These questions are not as compelling as peak experiences or cutting-edge tools. They are also where sustained change tends to occur.
Patients often present after a significant experience (psychedelic or technological) and ask why the effects didn’t last. In many cases, the answer lies not in the experience itself, but in the absence of a structure to support it.
Two traditions have long recognized this.
Recovery communities have emphasized for decades that transformation is not sustained by a single experience, but by ongoing relational and behavioral practices.
Indigenous traditions have embedded these practices within continuous community structures, where there is no clear separation between “experience” and “integration.”
In both cases, the insight is the same: without a stable container, change cannot hold.
Where the Container Could Live
This is where I believe an important opportunity exists.
Much of modern psychedelic work and digital health innovation is not designed for the long arc: the months and years required for change to stabilize. Clinical trials are often short-term. Retreats are time-limited. Many interventions are episodic.
Functional medicine, when practiced with depth and restraint, can be structured differently. Its focus is not on producing altered states, but on supporting the biological conditions that allow any state (insight, calm, presence) to be sustained.
This includes areas such as sleep architecture, metabolic function, inflammatory processes, and gut-brain signaling. These are not separate from mental health; they are part of its foundation.
At the same time, this field is not immune to the same risks. Functional medicine can become another form of optimization, reducing complex human experiences to biochemical pathways or protocols.
The version of this work that holds promise is one that remains aware of its limits, one that recognizes biological and experiential knowledge as complementary rather than competing frameworks.
That is the direction I am working toward.
Where I Stand
When I think about that patient (the one considering both AI tools and a psilocybin retreat), I come back to a simple observation.
The tools are not inherently the problem, nor are they inherently the solution.
What matters is how they are being used. Whether they are helping someone avoid what is most needed or creating space to engage with it.
Neither direction, on its own, resolves the underlying issue.
The growing interest in both artificial intelligence and plant medicine reflects something deeper: a recognition that the current way of being conscious, of moving through the world, relating to others, and inhabiting the body, is not working for many people.
At FxMed Mental Health, the work we are building is based on a simple premise: many people with complex mental health concerns are not treatment-resistant. They are under-tested and under-supported over time.
Our focus is on the long arc: the biological, psychological, and relational foundations that allow meaningful change to take hold.
Because the question is not which tool to choose.
It is what kind of life, and what kind of consciousness, we are actually trying to build.
Until that question is addressed directly, both movements will continue offering partial answers to a problem they are not designed to fully solve.
Let’s dig deeper into the intersection of AI and plant medicine.
Onward 🌱